Reduction or Extension of COnduction Time With Ventricular Electromechanical Remodeling (RECOVER)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-20

Study Completion Date

2024-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective multicenter registry study aims to detect the serial changes in ventriculo-ventricular conduction times according to cardiac-resynchronization therapy response.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe)

NCT05971225

Congestive Heart Failure Defibrillators Cardiac Resynchronization Therapy

RECRUITING NA

Atrial Sensing Capability for Better Detection of Atrial Fibrillation

NCT03932604

Implantable Cardioverter Defibrillator Atrial Fibrillation Cardiac Event +1 more

UNKNOWN NA

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial

NCT00251251

Heart Failure, Congestive

COMPLETED NA

RECOVER-HF Pilot Study of SDS in Heart Failure

NCT05592392

Heart Failure With Reduced Ejection Fraction

COMPLETED NA

Sensor Optimization of Cardiac Resynchronization Therapy Response

NCT01832493

Heart Failure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CRT responder

Device interrogation

Intervention Type DIAGNOSTIC_TEST

Ventriculo-ventricular conduction time measurement using device analyzer

CRT non-responder

Device interrogation

Intervention Type DIAGNOSTIC_TEST

Ventriculo-ventricular conduction time measurement using device analyzer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Device interrogation

Ventriculo-ventricular conduction time measurement using device analyzer

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* meeting the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for cardiac-resynchronization (CRT) implant

Exclusion Criteria

* Myocardial infarction, unstable angina within 40 days prior the enrollment
* Recent cardiac revascularization in the 4 weeks prior to the enrollment or planned for the 3 months following
* Cerebrovascular accident (CVA) or transient ischemic attack (TIA) in the 3 months prior to the enrollment
* Primary valvular disease requiring surgical correction
* Pregnant or are planning during the duration of the investigation
* Status 1 candidate for cardiac transplantation or consideration for transplantation over the next 12 months
* Post-cardiac transplantation
* Life expectancy \< 12 months
* Currently participating in any other clinical investigation except for observational registry

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No